Innoviva, Inc. (INVA)
Total Valuation
Innoviva has a market cap or net worth of $893.37 million. The enterprise value is $1.14 billion.
| Market Cap | 893.37M |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Wednesday, November 1, 2023, after market close.
| Earnings Date | Nov 1, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 64.09 million shares outstanding. The number of shares has decreased by -10.09% in one year.
| Shares Outstanding | 64.09M |
| Shares Change (YoY) | -10.09% |
| Shares Change (QoQ) | +31.57% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 110.39% |
| Float | 52.21M |
Valuation Ratios
The trailing PE ratio is 19.01 and the forward PE ratio is 18.14. Innoviva's PEG ratio is 0.24.
| PE Ratio | 19.01 |
| Forward PE | 18.14 |
| PS Ratio | 3.02 |
| Forward PS | 3.75 |
| PB Ratio | 1.40 |
| P/FCF Ratio | 7.54 |
| PEG Ratio | 0.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 9.82.
| EV / Earnings | 22.92 |
| EV / Sales | 3.94 |
| EV / EBITDA | 9.67 |
| EV / EBIT | 13.38 |
| EV / FCF | 9.82 |
Financial Position
The company has a current ratio of 8.43, with a Debt / Equity ratio of 0.71.
| Current Ratio | 8.43 |
| Quick Ratio | 6.85 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | 3.83 |
| Interest Coverage | 4.96 |
Financial Efficiency
Return on equity (ROE) is 8.60% and return on invested capital (ROIC) is 6.38%.
| Return on Equity (ROE) | 8.60% |
| Return on Assets (ROA) | 4.30% |
| Return on Capital (ROIC) | 6.38% |
| Revenue Per Employee | $2.88M |
| Profits Per Employee | $493,832 |
| Employee Count | 101 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.71 |
Taxes
In the past 12 months, Innoviva has paid $18.33 million in taxes.
| Income Tax | 18.33M |
| Effective Tax Rate | 26.88% |
Stock Price Statistics
The stock price has increased by +6.29% in the last 52 weeks. The beta is 0.50, so Innoviva's price volatility has been lower than the market average.
| Beta (1Y) | 0.50 |
| 52-Week Price Change | +6.29% |
| 50-Day Moving Average | 13.23 |
| 200-Day Moving Average | 12.65 |
| Relative Strength Index (RSI) | 56.08 |
| Average Volume (30 Days) | 692,515 |
Short Selling Information
The latest short interest is 9.61 million, so 14.99% of the outstanding shares have been sold short.
| Short Interest | 9.61M |
| Short Previous Month | 8.97M |
| Short % of Shares Out | 14.99% |
| Short % of Float | 18.40% |
| Short Ratio (days to cover) | 12.81 |
Income Statement
In the last 12 months, Innoviva had revenue of $290.43 million and earned $49.88 million in profits. Earnings per share was $0.72.
| Revenue | 290.43M |
| Gross Profit | 250.80M |
| Operating Income | 93.63M |
| Pretax Income | 68.21M |
| Net Income | 49.88M |
| EBITDA | 118.16M |
| EBIT | 85.44M |
| Earnings Per Share (EPS) | $0.72 |
Balance Sheet
The company has $180.00 million in cash and $445.72 million in debt, giving a net cash position of -$265.72 million or -$4.15 per share.
| Cash & Cash Equivalents | 180.00M |
| Total Debt | 445.72M |
| Net Cash | -265.72M |
| Net Cash Per Share | -$4.15 |
| Equity / Book Value | 627.49M |
| Book Value Per Share | 9.79 |
| Working Capital | 268.82M |
Cash Flow
In the last 12 months, operating cash flow was $116.71 million and capital expenditures -$294,000, giving a free cash flow of $116.41 million.
| Operating Cash Flow | 116.71M |
| Capital Expenditures | -294,000 |
| Free Cash Flow | 116.41M |
| FCF Per Share | $1.79 |
Margins
Gross margin is 86.36%, with operating and profit margins of 32.24% and 17.17%.
| Gross Margin | 86.36% |
| Operating Margin | 32.24% |
| Pretax Margin | 23.49% |
| Profit Margin | 17.17% |
| EBITDA Margin | 40.68% |
| EBIT Margin | 29.42% |
| FCF Margin | 40.08% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 5.68% |
| FCF Yield | 13.27% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.09% |
| Shareholder Yield | 10.09% |
Analyst Forecast
The average price target for Innoviva is $15.17, which is 9.02% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.17 |
| Price Target Difference | 9.02% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 3, 2014. It was a forward split with a ratio of 1241:1000.
| Last Split Date | Jun 3, 2014 |
| Split Type | Forward |
| Split Ratio | 1241:1000 |
Scores
Innoviva has an Altman Z-Score of 1.59 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.59 |
| Piotroski F-Score | 6 |